A detailed history of B. Metzler Seel. Sohn & Co. Ag transactions in Insulet Corp stock. As of the latest transaction made, B. Metzler Seel. Sohn & Co. Ag holds 9,542 shares of PODD stock, worth $2.59 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares
9,542
Previous 45,471 79.02%
Holding current value
$2.59 Million
Previous $9.18 Million 75.81%
% of portfolio
0.02%
Previous 0.1%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 08, 2024

SELL
$180.69 - $239.01 $6.49 Million - $8.59 Million
-35,929 Reduced 79.02%
9,542 $2.22 Million
Q2 2024

Aug 13, 2024

BUY
$161.02 - $206.98 $120,765 - $155,235
750 Added 1.68%
45,471 $9.18 Million
Q1 2024

May 15, 2024

BUY
$163.6 - $209.11 $1.56 Million - $2 Million
9,561 Added 27.19%
44,721 $7.67 Million
Q4 2023

Feb 13, 2024

BUY
$127.77 - $221.42 $3.67 Million - $6.36 Million
28,719 Added 445.88%
35,160 $7.63 Million
Q3 2023

Nov 13, 2023

BUY
$154.67 - $290.89 $260,464 - $489,858
1,684 Added 35.4%
6,441 $1.03 Million
Q2 2023

Aug 11, 2023

BUY
$272.48 - $330.23 $322,071 - $390,331
1,182 Added 33.06%
4,757 $1.37 Million
Q1 2023

May 10, 2023

BUY
$276.36 - $326.03 $237,669 - $280,385
860 Added 31.68%
3,575 $1.14 Million
Q4 2022

Feb 13, 2023

SELL
$212.22 - $313.46 $225,165 - $332,581
-1,061 Reduced 28.1%
2,715 $799,000
Q3 2022

Nov 14, 2022

SELL
$224.6 - $281.45 $24,481 - $30,678
-109 Reduced 2.81%
3,776 $866,000
Q2 2022

Aug 12, 2022

SELL
$186.4 - $279.02 $35,229 - $52,734
-189 Reduced 4.64%
3,885 $847,000
Q1 2022

May 10, 2022

BUY
$194.8 - $275.7 $73,829 - $104,490
379 Added 10.26%
4,074 $1.09 Million
Q4 2021

Feb 11, 2022

BUY
$255.32 - $318.29 $943,407 - $1.18 Million
3,695 New
3,695 $996,000

Others Institutions Holding PODD

About INSULET CORP


  • Ticker PODD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 69,403,600
  • Market Cap $18.9B
  • Description
  • Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes. It offers Omnipod System, a self-adhesive disposable tubeless Omnipod device that is worn on the body for up to three days at a time, as well as its wireless companion, the handheld personal diabetes manager. The company sel...
More about PODD
Track This Portfolio

Track B. Metzler Seel. Sohn & Co. Ag Portfolio

Follow B. Metzler Seel. Sohn & Co. Ag and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of B. Metzler Seel. Sohn & Co. Ag, based on Form 13F filings with the SEC.

News

Stay updated on B. Metzler Seel. Sohn & Co. Ag with notifications on news.